trial

Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use

NCTId NCT05445180

as of 2026-07-01

Add to landscape Monitor this Ask about this

at a glance

— · Recruiting

Enrollment 134 (estimated)

Sponsored by Douglas Mental Health University Institute

Primary completion 2027-05

Synthesized from structured facts only — each point cited above.

Design & status

Phase

—

Status

Recruiting

Enrollment

134 (estimated)

Study type

Interventional

Allocation

Randomized

Model

Parallel

Masking

Single

Start

2022-04-21

Primary completion

2027-05

Eligibility

ALL · 16 Years · 80 Years

Interventions & indications

Drugs

Contingency management

Indications

Schizophrenia; Psychosis Psychotic Disorders Cannabis Use Disorder Memory Impairment Memory Disorders Cognitive Dysfunction Marijuana Abuse Psychotic Disorders Neuroimaging Schizophrenia Cannabis Use Cannabis Dependence

Investigators

Rachel Rabin, Ph. D.Principal Investigator

Sites

1 total

Montreal, Canada

Facts & assertions

4 sourced

Enrollment

134

Phase

Primary Completion Date

2027-05

Status

RECRUITING

relationships

The graph out of here

drug

Contingency management

drug

lead_sponsor

Douglas Mental Health University Institute

company

indication

Schizophrenia; Psychosis

indication

Psychotic Disorders

indication

Cannabis Use Disorder

indication

investigator

Rachel Rabin, Ph. D.

person